|
William Jenkins MD has served as a director since September 2000. Dr. Jenkins has been a consultant and advisor to pharmaceutical companies and investment and venture capital firms in the health sector since 1999. From 1997 to 1999 he served as Head of Clinical Development and Regulatory Affairs for Ciba-Geigy and later for post-merger Novartis Pharma AG. Prior to that Dr. Jenkins was Head of Worldwide Clinical Research at Glaxo and a Deputy Head in the UK Drug Regulatory Agency. Dr. Jenkins is a member of the board of directors of Tanox Inc. BTG plc Glycart AG Esbatech AG and Eurand Pharmaceutical Holdings BV. Dr. Jenkins received his MD from Cambridge University and has a specialist accreditation in internal medicine and gastroenterology. | 